Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2.
- 1 September 1992
- journal article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 89 (17) , 8327-8331
- https://doi.org/10.1073/pnas.89.17.8327
Abstract
Glucocorticoid-suppressible hyperaldosteronism (GSH) is an autosomal dominant form of familial hypertension. The biochemical abnormalities seen in this disorder may be remedied by administration of dexamethasone, implying that aldosterone synthesis is being abnormally regulated by corticotropin. The final three steps of aldosterone synthesis, 11 beta- and 18-hydroxylation and 18-oxidation, are mediated by a cytochrome P450 in the zona glomerulosa of the adrenal cortex termed CYP11B2. A related isozyme in the zona fasciculata, CYP11B1, is required for cortisol synthesis; this isozyme, which is normally expressed at much higher levels than CYP11B2, only has 11 beta-hydroxylase activity. These isozymes are encoded by genes on human chromosome 8q22. We have now studied four unrelated patients with GSH. We found that each patient has one chromosome that carries three CYP11B genes instead of two. This has presumably been generated by unequal meiotic crossing-over. The extra gene is a hybrid with 5' regulatory and coding regions corresponding to CYP11B1 and 3' coding regions from CYP11B2. The breakpoint is in intron 2 in two cases, intron 3 in one, and exon 4 in one. Cells transfected with hybrid cDNAs containing up to the first three exons of CYP11B1 synthesized aldosterone at levels near that of cells carrying normal CYP11B2, but cells transfected with hybrids containing the first five or more exons of CYP11B1 could not synthesize detectable amounts of aldosterone. These data demonstrate that GSH is caused by expression of a gene that is regulated like CYP11B1 but that encodes a protein able to synthesize aldosterone.Keywords
This publication has 24 references indexed in Scilit:
- Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency.Proceedings of the National Academy of Sciences, 1992
- Genetic basis of endocrine disease 2: congenital adrenal hyperplasia due to 21-hydroxylase deficiency.Journal of Clinical Endocrinology & Metabolism, 1992
- A chimaeric llβ-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertensionNature, 1992
- Different Isozymes of Mouse 11/ß-Hydroxylase Produce Mineralocorticoids and GlucocorticoidsMolecular Endocrinology, 1991
- The Product of the CYP11B2 Gene Is Required for Aldosterone Biosynthesis in the Human Adrenal CortexMolecular Endocrinology, 1991
- Aldosterone synthase cytochrome P-450 expressed in the adrenals of patients with primary aldosteronismJournal of Biological Chemistry, 1991
- A mutation in CYP11B1 (Arg-448----His) associated with steroid 11 beta-hydroxylase deficiency in Jews of Moroccan origin.Journal of Clinical Investigation, 1991
- Defective Fasciculata Zone Function as the Mechanism of Glucocorticoid-Remediable Aldosteronism*Journal of Clinical Endocrinology & Metabolism, 1990
- AUTOSOMAL DOMINANT TRANSMISSION AND ABSENCE OF HLA LINKAGE IN DEXAMETHASONE SUPPRESSIBLE HYPERALDOSTERONISMThe Lancet, 1980
- Mineralocorticoids, salt balance and blood pressure after prolonged ACTH administration in juvenile hypertensionKlinische Wochenschrift, 1978